The invention aims at providing blood-brain barrier disruption inhibitors.
本发明的目的在于提供一种血脑屏障破坏的抑制剂。
Reactive oxygen species (ROS) are mediators of demyelination and disruption of the blood-brain barrier (BBB).
活性氧簇(ROS)是神经系统脱髓鞘及血脑屏障破坏的媒介。
This was accompanied by severe disruption of the blood-brain barrier and an increased rate of intracerebral hemorrhages after tissue plasminogen activator treatment.
这一现象伴随血脑屏障的严重破坏和组织型纤维蛋白溶酶原激活剂治疗后的脑出血率增加。
应用推荐